(Q46840300)

English

Detection of the moderately beneficial cognitive effects of low-dose treatment with haloperidol or clozapine in an animal model of the attentional impairments of schizophrenia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18094665

Detection of the moderately beneficial cognitive effects of low-dose treatment with haloperidol or clozapine in an animal model of the attentional impairments of schizophrenia (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18094665

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Vicente Martinez

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18094665

Martin Sarter

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18094665

language of work or name

0 references

publication date

19 December 2007

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18094665

Neuropsychopharmacology

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18094665

33

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18094665

11

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18094665

2635-2647

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18094665

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301661

0 references

The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional task-performing rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Preattentional and attentional cognitive deficits as targets for treating schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Differential effects of haloperidol and clozapine on attention.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Cortical cholinergic function and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesions of the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Improvement of prefrontal brain function in endogenous psychoses under atypical antipsychotic treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

The amphetamine-induced sensitized state as a model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Effort and cognition in schizophrenia patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: disruption by cocaine sensitization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Predicting drug efficacy for cognitive deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Baseline neurocognitive deficits in the CATIE schizophrenia trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Mechanisms of action of atypical antipsychotic drugs: a critical analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Augmented prefrontal acetylcholine release during challenged attentional performance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Increased dopamine transmission in schizophrenia: relationship to illness phases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Time course of the antipsychotic effect and the underlying behavioral mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Sensitized attentional performance and Fos-immunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Lateralized attentional functions of cortical cholinergic inputs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Neuronal activity in the nucleus accumbens is necessary for performance-related increases in cortical acetylcholine release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Stimulation of cortical acetylcholine release following blockade of ionotropic glutamate receptors in nucleus accumbens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Prefrontal acetylcholine release controls cue detection on multiple timescales

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Synthesizing schizophrenia: a bottom-up, symptomatic approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Preclinical research into cognition enhancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Abnormal neurotransmitter release underlying behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

More attention must be paid: the neurobiology of attentional effort

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Cortical cholinergic transmission and cortical information processing in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Relations of symptoms to cognitive deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

A putative animal model of the "prodromal" state of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Multiple dopamine D4 receptor variants in the human population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

Glutamate receptors in nucleus accumbens mediate regionally selective increases in cortical acetylcholine release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

21 January 2018

A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

7 January 2021

based on heuristic

inferred from DOI database lookup

Linear pharmacokinetics of haloperidol in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

7 January 2021

based on heuristic

inferred from DOI database lookup

A model of anticholinergic activity of atypical antipsychotic medications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect sizes and p values: what should be reported and what should be replicated?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained attention performance in rats with intracortical infusions of 192 IgG-saporin-induced cortical cholinergic deafferentation: effects of physostigmine and FG 7142.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

7 January 2021

based on heuristic

inferred from DOI database lookup

Towards a muscarinic hypothesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

7 January 2021

based on heuristic

inferred from DOI database lookup

Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301661

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1301661

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18094665

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18094665

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46840300&oldid=2134452682"